Clinical Trial

Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Whole blood clotting time measurements are to collect the clotting time ranges for DOAC-anticoagulated patients and assess their correlation with plasma drug levels (via anti-FXa assay).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-30.
Trial Details
NCT Number NCT06582563
Lead Sponsor Perosphere Technologies Inc.
Conditions Blood Coagulation Disorder
Enrollment 120 participants
Start Date 2025-03-01
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-08